Acquiring Company
Curavit Clinical Research
Acquired Company
Lindus Health
Description
Curavit Clinical Research has acquired the CRO assets of Lindus Health, expanding its capabilities in clinical research. This acquisition allows Curavit to offer unified clinical trial solutions across North America and Europe. The transaction facilitates faster recruitment and streamlined operations for life science sponsors. This strategic move addresses the growing demands of life science companies for efficient trial execution.
Quick answer
Curavit Clinical Research is acquiring Lindus Health, announced August 18, 2026. Curavit Clinical Research is based in Scarsdale, New York, United States.
- How much did Curavit Clinical Research pay for Lindus Health?
- The deal value was not disclosed.
- What does Curavit Clinical Research do?
- Curavit, the “First All-Virtual CRO", designs and executes decentralized - or “virtual” - clinical trials.
- Where are Curavit Clinical Research and Lindus Health based?
- Curavit Clinical Research is based in Scarsdale, New York, United States.
- Who are the decision-makers at Curavit Clinical Research?
- Fundz holds 1 contact at Curavit Clinical Research. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Healthcare and Therapeutics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Yarrow Bioscience completes merger with VYNE Therapeutics (July 27, 2026)
- Ambros Therapeutics to merge with Werewolf Therapeutics (August 21, 2026)
- Vertex to acquire Crinetics Pharmaceuticals for $10B, $10B (July 6, 2026)
- SpyGlass Pharma, Inc. Acquires Santen Holdings US, Inc. (October 1, 2026)
- Aethlon Medical to merge with North Immunology (September 17, 2026)
- Yarrow Bioscience, Inc. Completes Merger with Yarrow Bioscience Operating Company Corp. (September 10, 2026)
Who to call at Curavit Clinical Research, and when
When Curavit Clinical Research changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Curavit Clinical Research raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Curavit Clinical Research, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Curavit Clinical Research. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Curavit Clinical Research makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Lindus Health?
Lindus Health was acquired by Curavit Clinical Research, based in Scarsdale. The deal was reported on August 18, 2026. Curavit, the “First All-Virtual CRO", designs and executes decentralized - or “virtual” - clinical trials. Curavit Clinical Research is privately held and operates in Biotechnology.
When did Curavit Clinical Research acquire Lindus Health?
Curavit Clinical Research's acquisition of Lindus Health was reported on August 18, 2026. Curavit Clinical Research has acquired the CRO assets of Lindus Health, expanding its capabilities in clinical research. This acquisition allows Curavit to offer unified clinical trial solutions across North America and Europe. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Lindus Health do?
Lindus Health’s mission is to fix this problem, to enable the next generation of healthcare. Lindus Health is focused on working with start-ups and growth companies to deliver trials better, faster, and cheaper. It is privately held, operating in Software.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.